Synthesis, biological activity and multiscale molecular modeling studies for coumaryl-carboxamide derivatives as selective carbonic anhydrase IX inhibitors

References

• Pocker Y, Sarkanen S, Carbonic anhydrase: structure, catalytic versatility, and inhibition, in advances in enzymology and related areas of molecular biology. In: Meister A, ed. Hoboken, NJ: John Wiley & Sons, Inc; 1979;47:149–274.
   Google Scholar
• Carter MJ. Carbonic anhydrase; isoenzymes, properties, distribution, and functional significance. Biol Rev 1972;42:465–513.
   Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Future Med Chem 2011;3:1165–80.
   PubMed Web of Science ®Google Scholar
• Cornelio B, Laronze-Cochard M, Ceruso M, et al. Arylbenzenesulfonamides as human carbonic anhydrase inhibitors (hCAIs): synthesis by Pd nanocatalyst-mediated Suzuki − Miyaura reaction, enzyme inhibition, and X-ray crystallographic studies. J Med Chem 2016;59:721–32.
   PubMed Web of Science ®Google Scholar
• Karioti A, Ceruso M, Carta F, et al. New natural product carbonic anhydrase inhibitors incorporating phenol moieties. Bioorg Med Chem 2015;23:7219–25.
   PubMed Web of Science ®Google Scholar
• Özgeris B, Göksu S, Köse LP, et al. Acetylcholinesterase and carbonic anhydrase inhibitory properties of novel urea and sulfamide derivatives incorporating dopaminergic 2-aminotetralin scaffolds. Bioorg Med Chem 2016;24:2318–29.
   PubMed Web of Science ®Google Scholar
• Villalba ML, Palestro P, Ceruso M, et al. Sulfamide derivatives with selective carbonic anhydrase VII inhibitory action. Bioorg Med Chem 2016;24:894–901.
   PubMed Web of Science ®Google Scholar
• Fossati S, Giannoni P, Solesio ME, et al. The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain. Neurobiol Dis 2016;86:29–40.
   PubMed Web of Science ®Google Scholar
• Leppilampi M, Koistinen P, Savolainen ER, et al. The expression of carbonic anhydrase II in hematological malignancies. Clin Cancer Res 2002;8:2240–5.
   PubMed Web of Science ®Google Scholar
• Carta F, Osman SM, Vullo D, et al. Dendrimers incorporating benzenesulfonamide moieties strongly inhibit carbonic anhydrase isoforms I–XIV. Org Biomol Chem 2015;13:6453–7.
   PubMed Web of Science ®Google Scholar
• El-Azab AS, Abdel-Aziz AAM, Ayyad RR, et al. Inhibition of carbonic anhydrase isoforms I, II, IV, VII and XII with carboxylates and sulfonamides incorporating phthalimide/phthalic anhydride scaffolds. Bioorg Med Chem 2016;24:20–5.
   PubMed Web of Science ®Google Scholar
• Ombouma J, Vullo D, Dumy P, et al. Carbonic Anhydrase Glycoinhibitors belonging to the Aminoxysulfonamide Series. ACS Med Chem Lett 2015;6:819–21.
   PubMed Web of Science ®Google Scholar
• Barresi E, Salerno S, Marini AM, et al. Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII. Bioorg Med Chem 2016;24:921–7.
   PubMed Web of Science ®Google Scholar
• Bozdag M, Pinard M, Carta F, et al. A class of 4-sulfamoylphenyl-ω-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects. J Med Chem 2014;57:9673–86.
   PubMed Web of Science ®Google Scholar
• De Simone G, Supuran CT. Carbonic anhydrase IX: biochemical and crystallographic characterization of a novel antitumor target. Biochim Biophys Acta 2010;1804:404–9.
   PubMed Web of Science ®Google Scholar
• Nishimori I, Vullo D, Minakuchi T, et al. Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition. Bioorg Med Chem Lett 2013;23:256–60.
   PubMed Web of Science ®Google Scholar
• Said HM, Supuran CT, Hageman C, et al. Modulation of carbonic anhydrase 9 (CA9) in human brain cancer. Curr Pharm Des 2010;16:3288–99.
   PubMed Web of Science ®Google Scholar
• Guler OO, De Simone G, Supuran CT. Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII. Curr Med Chem 2010;17:1516–26.
   PubMed Web of Science ®Google Scholar
• Akurathi V, Dubois L, Lieuwes NG, et al. Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia. Nucl Med Biol 2010;37:557–64.
   PubMed Web of Science ®Google Scholar
• Genis C, Sippel KH, Case N, et al. Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties. Biochemistry 2009;48:1322–31.
   PubMed Web of Science ®Google Scholar
• Thiry A, Supuran CT, Masereel B, Dogne JM. Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs. J Med Chem 2008;51:3051–6.
   PubMed Web of Science ®Google Scholar
• Meijer TW, Bussink J, Zatovicova M, et al. Tumor microenvironmental changes induced by the sulfamate carbonic anhydrase IX inhibitor S4 in a laryngeal tumor model. PLoS One 2014;9:e108068.
   PubMed Web of Science ®Google Scholar
• Krall N, Pretto F, Decurtins W, et al. A small molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors. Angew Chem Int Ed Engl 2014;53:4231–5.
   PubMed Web of Science ®Google Scholar
• Pastorek J, Pastorekova S. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use. Semin Cancer Biol 2015;31:52–64.
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Pochet L, et al. Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem 2010;53:335–44.
   PubMed Web of Science ®Google Scholar
• Touisni N, Maresca A, McDonald PC, et al. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors. J Med Chem 2011;54:8271–7.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Carta F, Ceruso M, et al. Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII. Bioorg Med Chem 2015;23:6955–66.
   PubMed Web of Science ®Google Scholar
• Bozdag M, Ferraroni M, Carta F, et al. Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups. J Med Chem 2014;57:9152–67.
   PubMed Web of Science ®Google Scholar
• Grandane A, Tanc M, Di Cesare Mannelli L, et al. 6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells. J Med Chem 2015;58:3975–83.
   PubMed Web of Science ®Google Scholar
• Tanc M, Carta F, Bozdag M, et al. 7-Substituted-sulfocoumarins are isoform-selective, potent carbonic anhydrase II inhibitors. Bioorg Med Chem 2013;21:4502–10.
   PubMed Web of Science ®Google Scholar
• Ferraroni M, Carta F, Scozzafava A, Supuran CT. Thioxocoumarins show an alternative carbonic anhydrase inhibition mechanism compared to coumarins. J Med Chem 2016;59:462–73.
   PubMed Web of Science ®Google Scholar
• Imran S, Taha M, Ismail NH, et al. Synthesis, biological evaluation, and docking studies of novel thiourea derivatives of bisindolylmethane as carbonic anhydrase II inhibitor. Bioorg Chem 2015;62:83–93.
   PubMed Web of Science ®Google Scholar
• Zaib S, Saeed A, Stolte K, et al. New aminobenzenesulfonamide-thiourea conjugates: synthesis and carbonic anhydrase inhibition and docking studies. Eur J Med Chem 2014;78:140–50.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors - Part 94. 1,3,4-Thiadiazole-2-sulfonamide derivatives as antitumor agents. Eur J Med Chem 2000;35:867–74.
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Arylsulfonylureido and arylureido-substituted aromatic and heterocyclic sulfonamides: towards selective inhibitors of carbonic anhydrase isozyme I. J Enzyme Inhib 1999;14:343–63.
   PubMed Web of Science ®Google Scholar
• Pacchiano F, Carta F, McDonald PC, et al. Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J Med Chem 2011;54:1896–902.
   PubMed Web of Science ®Google Scholar
• Yang Y, Liu QW, Shi Y, et al. Design and synthesis of coumarin-3-acylamino derivatives to scavenge radicals and to protect DNA. Eur J Med Chem 2014;84:1–7.
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Vu H, et al. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 2009;131:3057–62.
   PubMed Web of Science ®Google Scholar
• Maresca A, Scozzafava A, Supuran CT. 7,8-Disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range. Bioorg Med Chem Lett 2010;20:7255–8.
   PubMed Web of Science ®Google Scholar
• Wagner J, Avvaru BS, Robbins AH, et al. Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations. Bioorg Med Chem 2010;18:4873–8.
   PubMed Web of Science ®Google Scholar
• Tars K, Vullo D, Kazaks A, et al. Sulfocoumarins (1,2-Benzoxathiine-2,2-dioxides): A class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases. J Med Chem 2013;56:293–300.
   PubMed Web of Science ®Google Scholar
• Akincioglu A, Akincioglu H, Gulcin I, et al. Discovery of potent carbonic anhydrase and acetylcholine esterase inhibitors: novel sulfamoylcarbamates and sulfamides derived from acetophenones. Bioorg Med Chem 2015;23:3592–602.
   PubMed Web of Science ®Google Scholar
• Durdagi S, Scozzafava G, Vullo D, et al. Inhibition of mammalian carbonic anhydrases I-XIV with grayanotoxin III: solution and in silico studies. J Enzyme Inhib Med Chem 2014;29:469–75.
   PubMed Web of Science ®Google Scholar
• Salmas RE, Mestanoglu M, Durdagi S, et al. Kinetic and in silico studies of hydroxy-based inhibitors of carbonic anhydrase isoforms I and II. J Enzyme Inhib Med Chem 2016;31:31–7.
   PubMed Web of Science ®Google Scholar
• Kocak R, Akın ET, Kalin P, et al. Synthesis of some novel norbornene‐fused pyridazines as potent inhibitors of carbonic anhydrase and acetylcholinesterase. J Heterocyclic Chem 2015;53:2049–56.
   Web of Science ®Google Scholar
• Salmas RE, Senturk M, Yurtsever M, Durdagi S. Discovering novel carbonic anhydrase type IX (CA IX) inhibitors from seven million compounds using virtual screening and in vitro analysis. J Enzyme Inhib Med Chem 2016;31:425–33.
   PubMed Web of Science ®Google Scholar
• Isik S, Vullo D, Durdagi S, et al. Interaction of carbonic anhydrase isozymes I, II, and IX with some pyridine and phenol hydrazinecarbothioamide derivatives. Bioorg Med Chem Lett 2015;25:5636–41.
   PubMed Web of Science ®Google Scholar
• Fidan I, Salmas RE, Arslan M, et al. Carbonic anhydrase inhibitors: design, synthesis, kinetic, docking and molecular dynamics analysis of novel glycine and phenylalanine sulfonamide derivatives. Bioorg Med Chem 2015;23:7353–8.
   PubMed Web of Science ®Google Scholar
• Ghanei-Nasab S, Khoobi M, Hadizadehd F, et al. Synthesis and anticholinesterase activity of coumarin-3-carboxamides bearing tryptamine moiety. Eur J Med Chem 2016;121:40–6.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–73.
   PubMed Web of Science ®Google Scholar
• (a) Carta F, Maresca A, Scozzafava A, Supuran CT, Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII. Bioorg Med. Chem 2012;2:2266–73.
   Web of Science ®Google Scholar
  (b) Davis RA, Vullo D, Maresca A, et al. Natural product coumarins that inhibit human carbonic anhydrases. Bioorg Med Chem 2013;2:1539–43.
   Web of Science ®Google Scholar
  (c) Sharma A, Tiwari M, Supuran CT. Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX. J Enzyme Inhib Med Chem 2014;29:292–6.
   PubMed Web of Science ®Google Scholar
• Small-Molecule Drug Discovery Suite 2015-2. Schrödinger, LLC: New York, NY; 2015.
   Google Scholar
• Schrödinger Release 2015-2: LigPrep. Schrödinger, LLC: New York, NY; 2015.
   Google Scholar
• Halgren TA, Murphy RB, Friesner RA, et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 2004;47:1750–9.
   PubMed Web of Science ®Google Scholar
• Verdonk ML, Cole JC, Hartshorn MJ, et al. Improved protein-ligand docking using GOLD. Proteins: Struct Funct Genet 2003;52:609–23.
   PubMed Web of Science ®Google Scholar